News
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on HitIQ.
RELATED STOCKHEAD STORIES
News
CLOSING BELL: No, you haven’t hit your head… HIQ is up 75% today because it’s off to play in the Premier League
News
ASX Small Caps Lunch Wrap: Anyone else feeling a little bit topsy turvy today?
News
Rise and Shine: Everything you need to know before the ASX opens
News
Closing Bell: Local market on its knees after Fed’s big night of being tight; Norfolk Minerals up 137%
News
ASX Small Caps Lunch Wrap: Who wants to sign a petition to get Powell to stop saying stuff for a while?
Health & Biotech
ASX Health Stocks: HitIQ soars 40pc after signing footy deal; Rhythm Bio expands to NZ
News
Top 10 at 10: The tenacious ASX tech, copper and critical mineral stocks taking off on a tumultuous Thursday
News
Rise and Shine: What you need to know before the ASX opens
Health & Biotech
ASX Biotech Stocks: HitIQ nabs landmark deal with Premier League for its concussion management tech
Health & Biotech
ASX Biotech Stocks: Surgeons can now be reimbursed for using Orthocell’s nerve repair device
Experts
CRITERION: Gains without pains? Maybe tackle these sporting injury stocks instead
Health & Biotech
ASX Health Stocks: HITIQ signs renewed deal with English cricket to manage concussion injuries
News
Market Highlights: Fed comments to cripple markets and 5 ASX small caps to watch
Health & Biotech
ASX Health Stocks: Patrys says brain cancer drug is effective; HitIQ awarded Aussie patent
Health & Biotech
Check Up: These biotech themes got billions in VC funding. These ASX stocks could benefit
Health & Biotech
ASX Health Stocks: HitIQ and Volpara prove world class technology after signing major US deals
Health & Biotech
